Login to Your Account



Pharma: Other News To Note


Tuesday, February 14, 2012
• Merck & Co. Inc., of Whitehouse Station, N.J., said the FDA approved Zioptan (tafluprost ophthalmic solution) 0.0015 percent, a preservative-free prostaglandin analogue ophthalmic solution for reducing elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription